SUMMIT THERAPEUTICS INC (SMMT) Stock Balance Sheet
NASDAQ:SMMT • US86627T1088
Current stock price
17.94 USD
+2.4 (+15.44%)
At close:
17.7897 USD
-0.15 (-0.84%)
After Hours:
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 297.87M | 104.86M | 71.42M | 348.60M | 71.80M | |||
| Marketable Securities | 0.00 | 307.49M | 114.82M | N/A | N/A | |||
| Receivables | N/A | 557.00K | 848.00K | 6.10M | 17.20M | |||
| Other Current Assets | 11.37M | 10.84M | 2.62M | 302.00M | 8.40M | |||
| Total Current Assets | 309.24M | 423.75M | 189.71M | 656.70M | 97.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.24M | 7.40M | 6.06M | 5.10M | 3.50M | |||
| Goodwill | 2.04M | 1.86M | 1.89M | 1.80M | 2.00M | |||
| Intangibles | N/A | N/A | N/A | 0.00 | 10.40M | |||
| Other Non-Current Assets | 6.52M | 1.85M | 4.32M | 600.00K | 200.00K | |||
| Total Non-Current Assets | 14.80M | 11.81M | 13.24M | 7.50M | 16.10M | |||
| TOTAL ASSETS | 324.04M | 435.56M | 202.95M | 664.20M | 113.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 19.80M | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 35.86M | 35.30M | 17.02M | 18.00M | 12.40M | |||
| Accounts Payable | 22.98M | 4.64M | 2.67M | 400.00K | 4.40M | |||
| Other Current Liabilities | 1.49M | 1.80M | 717.00K | 700.00K | 8.80M | |||
| Total Current Liabilities | 60.33M | 41.73M | 20.41M | 38.80M | 25.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 100.00M | 494.50M | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 4.27M | 5.08M | 4.85M | 4.20M | 4.50M | |||
| Total Non-Current Liabilities | 4.27M | 5.08M | 104.85M | 498.70M | 4.50M | |||
| TOTAL LIABILITIES | 64.60M | 46.81M | 125.26M | 537.50M | 30.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.84B | -1.21B | -993.26M | -378.30M | -299.50M | |||
| Additional Paid In Capital | 2.10B | 1.60B | 1.07B | 504.80M | 384.00M | |||
| Common Shares | 7.43M | 7.38M | 7.02M | 2.10M | 1.00M | |||
| Other Shareholders' Equity | -2.75M | -2.29M | -2.45M | -1.90M | -2.20M | |||
| Shares Outstanding | 742.81M | 737.63M | 701.66M | 211.10M | 98.00M | |||
| Tangible Book Value per Share | 0.35 | 0.52 | 0.11 | 0.59 | 0.72 | |||
| Total Shareholders' Equity | 259.44M | 388.75M | 77.69M | 126.70M | 83.30M | |||
| TOTAL LIABILITIES AND EQUITY | 324.04M | 435.56M | 202.95M | 664.20M | 113.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 1.29 | 4.06 | N/A | |||
| Current Ratio | 5.13 | 10.15 | 9.30 | 16.93 | 3.80 | |||
| Return On Assets (ROA) | -230.24% | -50.81% | -303.00% | -11.86% | -78.13% | |||
| Return On Equity (ROE) | -287.57% | -56.93% | -791.49% | -62.18% | -106.36% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21